1. Home
  2. TELO vs VTGN Comparison

TELO vs VTGN Comparison

Compare TELO & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • VTGN
  • Stock Information
  • Founded
  • TELO 2021
  • VTGN 1998
  • Country
  • TELO United States
  • VTGN United States
  • Employees
  • TELO N/A
  • VTGN N/A
  • Industry
  • TELO
  • VTGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TELO
  • VTGN Health Care
  • Exchange
  • TELO NYSE
  • VTGN Nasdaq
  • Market Cap
  • TELO 58.6M
  • VTGN 70.0M
  • IPO Year
  • TELO 2024
  • VTGN N/A
  • Fundamental
  • Price
  • TELO $1.29
  • VTGN $2.01
  • Analyst Decision
  • TELO
  • VTGN
  • Analyst Count
  • TELO 0
  • VTGN 0
  • Target Price
  • TELO N/A
  • VTGN N/A
  • AVG Volume (30 Days)
  • TELO 426.9K
  • VTGN 183.5K
  • Earning Date
  • TELO 08-12-2025
  • VTGN 06-17-2025
  • Dividend Yield
  • TELO N/A
  • VTGN N/A
  • EPS Growth
  • TELO N/A
  • VTGN N/A
  • EPS
  • TELO N/A
  • VTGN N/A
  • Revenue
  • TELO N/A
  • VTGN $486,000.00
  • Revenue This Year
  • TELO N/A
  • VTGN N/A
  • Revenue Next Year
  • TELO N/A
  • VTGN $943.32
  • P/E Ratio
  • TELO N/A
  • VTGN N/A
  • Revenue Growth
  • TELO N/A
  • VTGN N/A
  • 52 Week Low
  • TELO $1.25
  • VTGN $1.90
  • 52 Week High
  • TELO $8.40
  • VTGN $4.21
  • Technical
  • Relative Strength Index (RSI)
  • TELO 22.85
  • VTGN 38.62
  • Support Level
  • TELO $1.65
  • VTGN $1.96
  • Resistance Level
  • TELO $1.81
  • VTGN $2.12
  • Average True Range (ATR)
  • TELO 0.15
  • VTGN 0.15
  • MACD
  • TELO -0.05
  • VTGN -0.02
  • Stochastic Oscillator
  • TELO 1.10
  • VTGN 11.61

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: